Security key
00847X104
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)
CUSIP: 00847X104
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, Par Value $0.001 per share
- Total 13F shares
- 61,946,791
- Total 13F value
- $1,811,267,450
- Share change
- +2,171,820
- Put/Call ratio
- 139%
- SEC-reported price per share
- $29.24
- Number of holders
- 183
- Value change
- +$89,235,062
- Number of buys
- 99
- Number of sells
- 79
- Shares outstanding
- 59,431,072
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q1 2024
Institutions
183
Top holders
10
AGIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2024
Previous quarter: Q4 2023
AGIOS PHARMACEUTICALS, INC. SEC filings
AGIOS PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00847X104
Recent filing periods:
Ownership snapshot
Top reported holders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 9.3%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 9.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
VANGUARD GROUP INC
9.3%
BlackRock Finance, Inc.
8.3%
FARALLON CAPITAL MANAGEMENT LLC
7%
Bellevue Group AG
6.7%
ARMISTICE CAPITAL, LLC
5.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
9.3%
|
$123,096,044
5,527,438 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
8.3%
|
$110,509,016
4,962,237 shares
|
— | 31 Dec 2023 |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
Company
|
7%
|
$92,812,497
4,167,602 shares
|
— | 31 Dec 2023 |
| Bellevue Group AG |
13F
Company
|
6.7%
|
$89,324,970
4,011,000 shares
|
— | 31 Dec 2023 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
5.9%
|
$78,479,480
3,524,000 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
4.4%
|
$58,474,005
2,625,685 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
183
Shares
61,946,791
Rows available
183
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
167
Q1 2024 holders
183
Holder diff
16
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend